ArticleNorthern clinics of Istanbul2023

Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder.

Zerrin Karaaslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.